Emerging Drugs and Targets for Multiple Sclerosis
Multiple sclerosis (MS) is a complex disease with a presumed autoimmune aetiology and few current effective treatments. Disease modifying therapies focus on the altering the natural course of relapsing and remitting MS, targeting the inflammatory response. Other targets involve tacking the cause of the disease – demyelination of axons through remyelination therapies. Due to several recent breakthroughs in the understanding of the pathophysiology of MS new targets for remyelination and immunomodulation are rapidly emerging. This book provides a comprehensive overview of drug discovery and development for the molecular basis of the disease, from new targets to drugs currently in clinical development, cellular and animal disease models to biomarkers for diagnosis and assessment in clinical trials. Emerging Drugs and Targets for Multiple Sclerosis is an ideal reference for any student or researcher interested in drug development for neurodegenerative diseases, autoimmune diseases and MS in particular.
List Price: $220.00 (Final bulk discount pricing is based on quantity)
Uh oh. It looks like this title is out of stock.
Did you know eBooks never run out? It's true. We have millions of titles available right now. You can download an eBook in seconds.
Why eBooks are the Smart Way to Go
Deep bulk discounts and $0 in shipping costs means you save big with bulk eBooks. Plus, eBooks are typically cheaper than print books.
Distribute your eBooks via text message, email, social media, and more using redeemable eBook codes. Users can get their eBook instantly.
Receive Readership Analytics & Redemption Reports for proven engagement and user data, including name and email address.
Want to make the smart switch to eBooks? CLICK HERE
Not convinced yet? No problem. We can still get you the print books you need. Fill out the request form below and a member of our sales team will be in touch quickly.
Request Bulk Purchase: